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Abstract— Consistency modeling for gene selection is a new 
topic emerging from our recent cancer bioinformatics research. 
We found that the result of classification or clustering on a 
training set was often quite different compared to using a 
testing set. Here, we address this as a consistency problem. In 
practice, the inconsistency of microarray datasets prevents 
many typical gene selection methods working properly for 
cancer diagnosis and prognosis. In an attempt to deal with this 
problem, we propose a new gene selection method in terms of 
performance based on consistency. 
I. INTRODUCTION 
The advent of microarray technology has made it possible 
to provide clinical decision support in complex disease 
diagnosis and prognosis area, especially in cancer treatment. 
In practice, DNA microarrays have been used for a variety 
of applications, such as separating tissue samples into two 
categories (e.g. healthy and diseased), predicting the clinical 
outcomes in response to cancer treatment and investigating 
the diagnosis outcomes in terms of the disease 
characteristics. It has been reported that the results of 
microarray experiments can be nearly 100% accurate [1, 2]  
Microarray technology is thus considered a revolution for 
studying all human disease, and effective therapy schemes 
for all complex diseases were predicted to be developed in a 
few years [3].   
A major challenge with microarray research is how to 
find differentially expressed genes which can be used for 
effective discriminating variables in relation to different 
conditions, such as healthy and diseased. In a typical 
microarray dataset, the number of genes normally far 
exceeds that of samples. For example, the breast cancer 
training dataset contains only 78 samples, but more than 
24,000 genes [4]. Furthermore, those genes usually include 
many redundant genes that can confuse a classifying 
algorithm. Therefore, selecting highly relevant genes from 
the dataset is a fundamental task for microarray researchers. 
Recently, the reproducibility of microarray studies has 
been debated in leading scientific journals, because it is seen 
as a crucial point in microarray technology application in 
medicine. The results of microarray experiments are 
difficult to reproduce due to the differences in the structures 
of microarray datasets produced in different laboratories. 
Recent work has attempted to establish effective validation 
rules to evaluate the reliability of microarray studies [5, 6]. 
We propose the concept of consistency to deal with this 
issue.
II.CONSISTENCY
A. Related work 
Probabilistic consistency analysis for gene selection 
method [7] is a recent novel approach that focuses on 
analyzing the common genes selected from two datasets. 
Consistency in this method is defined as follows: 
Suppose two microarray datasets Da and Db targeting the 
same bioinformatics task, each having same number of 
samples and genes. r is a ranking function generating two 
lists of sorted genes from the two datasets. Let s top-ranked 
genes in each case be selected and denoted by SETa and 
SETb. Then, the consistency C of this dataset is given by: 
C(r, s, Da, Db) = | SETa ŀ SETb|       (1) 
Consistency C is the number of genes in common 
between the two sets, and depends on ranking function, data 
and number of selected genes [7]. Mukherjee and his 
colleagues have applied this probabilistic consistency to 
their gene selection method for selecting truly differentially 
expressed genes under various conditions. In their gene 
selection process, the result of probabilistic consistency 
obtained from top-selected genes is used for optimizing the 
test statistics function. After hundreds of iterations, an 
optimized statistic function can be achieved based on the 
consistency. 
B. Proposed method 
The concept of consistency proposed by Mukherjee and 
his colleagues focuses on the common genes selected from 
two sampled datasets. However, it is not clear to what extent 
the “highly differentially expressed genes” selected in terms 
of consistency are related to the performance of the 
28classification and clustering of the microarray data. In other 
words, the performance of classification or clustering over a 
dataset may not be improved, though their gene selection 
method based on consistency is applied. Motivated by this 
issue, we propose a new consistency concept in terms of 
performance. 
The idea of our approach is using the result of consistency 
obtained from an operation (e.g. classification, clustering, 
etc.) to find differentially expressed genes for a microarray 
dataset. For most microarray datasets, there tends to be no 
agreement on which genes are highly differentially 
expressed, and consequently it is difficult to measure the 
reliability of any gene selection method. In practice, the 
performance of an operation over microarray data is a 
straightforward criterion for measuring the outcomes of 
microarray experiments. Our new solution is based on 
optimizing computation which takes consistency into 
account.
Our gene selection process is an optimization, in which a 
genetic algorithm is employed. Mutation operation is 
applied in the genetic algorithm for optimizing the gene 
selection function. As one of the operations of genetic 
algorithms, mutation is an adaptive heuristic search 
algorithm based on the evolutionary idea. The main strength 
of mutation operation is that it helps solution convergence 
over successive generations towards the global optimum. 
Meanwhile, it also can provide a fast, effective and robust 
search, because new combinations implicitly contain more 
important information than using just the top-ranked 
individuals. 
Consider a microarray dataset D pertaining to a 
bioinformatics task. Two subsets are randomly partitioned 
from D and denoted by Da and Db:
D = Da  Db   &   Da  Db= I       ( 2 )  
Given an operation function f (e.g. classification, 
clustering and etc.), and a gene selection function S over Da
and Db, consistency C can be defined as the difference 
between the performance of an operation over dataset Da
and Db:
C(f, S, Da, Db) = | Pa - Pb  |     (3) 
where Pa and Pb are computed by: 
Pi  =  f(Seti, Di) | i = {a, b}      (4) 
where Seta and Setb are the selected genes obtained by the 
gene selection function S over Da and that of Dbrespectively, 
such that: 
Seti = S (Di) | i = {a, b}        (5) 
The proposed gene selection algorithm is an optimizing 
process using an evolutionary function based on the 
consistency performance,   
Si = E(Si-1, Ci-1)   )                   ( 6 )  
The gene selection procedure can be summarized into the 
following steps: 
1. Set an initial dataset Set0 as a set of top-ranked genes 
from  D using a typical gene selection function, e.g. 
t-test or SNR algorithm. 
2. Apply the operation function f to Set0 to calculate the 
consistency C0:
C0 =  | f(Set0, Da) -  f(Set0, Db)|   (7) 
3. Mutation of gene selection. Use an evolutionary 
function to optimize the gene selection function. 
4. Compute the consistency Cƍ based on the evolutionary 
gene selection function: 
Cƍ =  | f(Setƍ, Da) -  f(Setƍ, Db)|   (8) 
where Setƍ is obtained via the optimized gene selection 
function. 
5. If Cƍ > C0, the consistency is improved due to the 
evolutionary gene selection function. Then, we set C0 = 
Cƍ and Set0 = Set. 
6. Repeat Steps 3-5 for N generations. 
7. Output the best Set obtained. 
The optimized gene selection method is achieved after N
generations based on the best consistency performance. 
III. EXPERIMENTS   
We evaluated our proposed concept for gene selection on 
four well-known benchmark microarray datasets, and 
compared the results with three existing methods, including 
the t-test, SNR (Signal Noise Ratio) and Data-adaptive [8] 
methods. The four datasets are:   
1. Golub’s ALL-AML Leukaemia training data [9] 
containing  38  bone  marrow  samples (27 ALL and 11 
AML). The dimensionality of this microarray data is 
7,129 probes from 6817 human genes.   
2. Colon Tumor dataset [10]. This dataset consists of 62 
samples collected from colon-cancer patients; 40 
samples are labeled as cancer and 22 are labeled as 
normal. Only 2,000 genes out of total 6,500 genes are 
selected into the dataset based on the confidence in the 
measured expression levels. 
3. Lymp4026 data [11] contains the expression levels of 
4026 genes across 47 samples in lymphoma patients.. 
Among them, 24 samples are from “germinal center 
B-like” group while 23 are “activated B-like” group. 
4. Central Nervous System (CNS) cancer data [12]. This 
29dataset contains 60 patient samples in which 21 are 
survivors and 39 are non-survivors.   
The number of top-ranked genes for function f in our 
experiment is set as 50. The number of selected top genes is 
usually in relation to the performance of the operation over 
datasets. Fewer genes may make the operation unreliable, 
whereas too many genes selected might introduce noise to 
the experiment. Previous studies indicate that a few dozen to 
a few hundred top-ranked genes can efficiently classify the 
different disease patterns in most microarray experiments. 
For example, the best classification result for the 
Lymphoma data occurs using approximately 50 to 200 top 
genes [13]. 
We have applied three gene selection methods to do the 
initial gene selection over the above four cancer microarrays, 
respectively. K-nearest neighbor (KNN) algorithm is used as 
the operation function f to do classification over four 
microarray datasets. The consistency is evaluated in terms 
of mean for 200 runs by Eq. (3), and its value ranges from 0 
to 1. The best value of consistency should be 0, which 
means the accuracies of classification of the two subsets Da
and Db are the same. If the value of consistency is 1, the 
classification accuracies of Da and Db are totally different. 
The value of performance Pa and Pb also ranges from 0 to 1, 
in which 1 means all the samples are 100% classified into 
the correct classes whilst 0 is the poorest accuracy. 
Leukaemia Colon Lymp4026 CNS 
t-test
0.0529 
r 0.0400 
0.1227 
r 0.0916 
0.0411 
r 0.0314 
0.0863 
r 0.0710
SNR
0.0455 
r 0.0383 
0.1123 
r 0.0853 
0.0421 
r 0.0299 
0.0985 
r 0.0744
Data-adaptive
0.0674 
r 0.0581 
0.1232 
r 0.0943 
0.0379 
r 0.0249 
0.1275 
r 0.0942
Table. 1. Comparisons of three methods in terms of performance based on 
consistency. The value of consistency is represented by mean  r standard 
deviation value.   
Table 1 shows different datasets have very different 
inherent consistency values. The consistency of Lymp4026 
and Leukaemia is significantly better than that of Colon and 
CNS data. In contrast, Colon data has the highest 
inconsistency that is nearly three times higher than the most 
consistent dataset (Lymp4026).   
In addition, the consistency is seen also varying over 
different gene selection methods. SNR method outperforms 
the other methods on three of the four datasets, while 
Data-adaptive method wins in the fourth dataset. Among 
these datasets, the best consistency occurs when 
Data-adaptive method is used for gene selection on 
Lymp4026 dataset. Thus, the consistency performance also 
depends on the gene selection method even on the same 
dataset. 
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  Fig 1. Comparison of three methods (t-test, SNR, Data-adaptive (DA) 
gene selection methods) on Lymp4026 data in terms of performance based 
on consistency. X axis represents the iteration times, and Y axis is the value 
of consistency via Eq. (3), classification accuracy of Da and Db (Pa and Pb)
respectively, which calculated by Eq. (4). 
Method 
Data
Consistency 
(a) Lymp4026 – t-test method 
(b) Lymp4026 – SNR method 
(c) Lymp4026 – DA method 
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Fig 2. Comparison of three methods on CNS dataset in terms of the 
performance based on consistency. 
As seen in Fig 1, for all three gene selection methods, the 
consistency of Lymp4026 data in terms of performance is 
stable, with lower values (closer to zero). Correspondingly, 
it displays better average classification performance (Pa and 
Pb) of Lymp4026 data. In contrast, in Figure 2 (a)–(c), CNS 
data shows more variability in both consistency and 
performance. Interestingly, we can see that better 
consistency is related to the high performance. In Fig (2), 
more variability is shown in the value of consistency, Pa and 
Pb using DA method, while t-test and SNR methods show 
less variability. 
The experimental results show the consistency and 
performance of microarray data can be improved by using 
appropriate methods for gene selection, though different 
data has different inherent consistency. We also find there is 
no gene selection method which is always the best for the 
above four microarray data in terms of consistency and 
performance.  
IV. DISCUSSION AND CONCLUSIONS 
We briefly outlined a new approach based on consistency 
in terms of performance in the assessment of existing gene 
selection methods for various microarray datasets. This 
approach is straightforward to show the strength of different 
gene selection algorithms, which can assist researchers to 
choose proper methods for doing various classifications and 
clustering over particular microarray data. 
We described a new gene selection method in terms of 
performance based on consistency. A genetic algorithm for 
the given initial gene selection function leads to an 
optimized gene selection method from a family of 
evolutionary functions. The performance of classification 
and clustering over the dataset based on consistency is 
improved simultaneously with the set of selected 
informative genes. 
In a set of experiments, we noticed that the results from 
different existing gene selection methods on the same data 
are quite similar. However, this is not sufficient to show 
which method fits best for the operation over a particular 
microarray data. Thus, we aim to revise our gene selection 
method in future work, which can be summarized into the 
following points: 
1. The consistency C could be computed as: 
C(f, S, Da, Db) = | f(Seta, Da) -  f(Seta, Db)|   (9) 
Where Setais computed by: 
 Seta = S (Da)             ( 1 0 )  
The consistency is independent on Db, which ensures the 
testing data has no relation with the computed consistency. 
We are currently working on this extended method. 
(a) CNS – t-test method 
(b) CNS – SNR method 
(c) CNS – DA method 
312. Only one operation over microarray datasets (KNN 
classification) was applied in our experiments. We will use 
other classification and clustering algorithms to do the 
validation of our proposed gene selection method.   
3. Design a new scheme for sampling the raw microarray 
dataset. In general, it is fairly difficult to detect what is the 
best splitting ratio for a particular dataset sampling. We are 
looking into the use of other methods for simple but 
effective sampling of raw microarray data. 
In conclusion, we have developed a new genetic 
algorithm approach for gene selection in terms of 
consistency. This method can be used in a variety of 
analysis tasks of high-dimensionality data, not only 
microarray data. Further development of the approach is in 
progress.   
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